Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
Vigil Neuroscience, Inc. (VIGL)
Company Research
Source: Yahoo! Finance
Given this risk, we thought we'd take a look at whether Vigil Neuroscience NASDAQ:VIGL ) shareholders should be worried about its cash burn. In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway. How Long Is Vigil Neuroscience's Cash Runway? A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. When Vigil Neuroscience last reported its June 2024 balance sheet in August 2024, it had zero debt and cash worth US$87m. Importantly, its cash burn was US$70m over the trailing twelve months. So it had a cash runway of approximately 15 months from June 2024. That's not too bad, but it's fair to say the end of the cash runway is in sight, unless cash burn reduces drastically. You can see how its cash balance has changed ove
Show less
Read more
Impact Snapshot
Event Time:
VIGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VIGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VIGL alerts
High impacting Vigil Neuroscience, Inc. news events
Weekly update
A roundup of the hottest topics
VIGL
News
- FDA lifts partial clinical hold on Vigil Neuroscience's Phase I VG-3927 trial [Yahoo! Finance]Yahoo! Finance
- Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927GlobeNewswire
- Vigil Neuroscience to Present at Cantor Global Healthcare ConferenceGlobeNewswire
- Vigil Neuroscience to Present at Upcoming September Investor ConferencesGlobeNewswire
- SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL)PR Newswire
VIGL
Earnings
- 8/13/24 - Beat
VIGL
Sec Filings
- 9/19/24 - Form 144
- 9/17/24 - Form 8-K
- 8/13/24 - Form 10-Q
- VIGL's page on the SEC website